Combiclav Suspension for Injection for Cattle 100ml

Combiclav Suspension for Injection for Cattle 100ml.

Target species

Cattle

Indications for use, specifying the target species

Combiclav Injection has a notably broad spectrum of bactericidal activity against the bacteria commonly found in cattle.

(a) In vitro Combiclav Injection is active against a wide range of clinically important bacteria including: Gram-positive: Staphylococci (including beta-lactamase producing strains), Streptococci, Corynebacteria, Clostridia, Bacillus anthracis, Actinomyces bovis. Gram-negative: Escherichia coli (including beta-lactamase producing strains), Salmonella spp (including beta-lactamase producing strains), Campylobacter spp, Klebsiella spp, Proteus spp, Pasteurella spp, Fusobacterium necrophorum, Bacteroides (including beta-lactamase producing strains), Haemophilus spp, Moraxella spp and Actinobacillus lignieresi.

(b) Clinically Combiclav Injection is effective in treating:

Cattle: Respiratory infections Soft tissue infections (e.g. joint/navel ill, abscesses etc.) Metritis Mastitis.

Combined Therapy for the treatment of bovine mastitis. In the situation where systemic treatment as well as intramammary treatment is necessary, Combiclav Injection can be administered in combination with Combiclav Lactating Cow Intramammary Suspension.